India, Nov. 25 -- Morphle Labs, a Bengaluru-based deep-tech healthcare automation startup building next-generation robotic and imaging systems for cancer diagnostics, has raised $5 million in a Series Around, byInflexor Ventures.

The funding will enable the company to accelerate global market expansion, scale manufacturing for its flagship products RoboTome(R)and MorphoLens, invest in global regulatory approvals, and deepen its technology and IP leadership as it expands into major international markets.

Founded in 2017, Morphle Labs is addressing one of the most underserved but critical aspects of healthcare: automation in histopathology, the core of cancer diagnostics.

The company's flagship platform,RoboTome(R), is the first robotic ...